Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$6.37 - $15.23 $248 - $593
39 Added 5.57%
739 $11,000
Q2 2022

Aug 03, 2022

SELL
$4.95 - $9.16 $108,900 - $201,520
-22,000 Reduced 96.92%
700 $5,000
Q1 2022

Apr 29, 2022

BUY
$5.64 - $9.8 $124,080 - $215,600
22,000 Added 3142.86%
22,700 $207,000
Q4 2021

Feb 03, 2022

SELL
$7.02 - $13.33 $55,338 - $105,080
-7,883 Reduced 91.84%
700 $5,000
Q3 2021

Oct 18, 2021

BUY
$11.32 - $16.63 $89,235 - $131,094
7,883 Added 1126.14%
8,583 $98,000
Q4 2020

Jan 25, 2021

SELL
$9.12 - $14.49 $57,884 - $91,968
-6,347 Reduced 90.07%
700 $9,000
Q3 2020

Oct 20, 2020

BUY
$10.46 - $14.46 $70,050 - $96,838
6,697 Added 1913.43%
7,047 $83,000
Q2 2020

Jul 27, 2020

SELL
$12.0 - $16.13 $11,400 - $15,323
-950 Reduced 73.08%
350 $5,000
Q1 2020

Apr 17, 2020

BUY
$11.84 - $25.52 $1,657 - $3,572
140 Added 12.07%
1,300 $18,000
Q4 2019

Jan 17, 2020

SELL
$17.72 - $25.1 $144,949 - $205,318
-8,180 Reduced 87.58%
1,160 $28,000
Q3 2019

Oct 17, 2019

BUY
$18.41 - $28.0 $168,083 - $255,640
9,130 Added 4347.62%
9,340 $180,000
Q1 2018

Apr 10, 2018

SELL
$51.15 - $61.0 $2,557 - $3,050
-50 Reduced 19.23%
210 $11,000
Q3 2017

Oct 13, 2017

BUY
$48.6 - $60.1 $12,636 - $15,626
260
260 $13,000

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.